Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
Introduction: In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindicatio...
Main Authors: | Flaminia Bardanzellu, Cristina Piras, Alessandra Atzei, Paola Neroni, Vassilios Fanos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2020.613749/full |
Similar Items
-
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
by: Flaminia Bardanzellu, et al.
Published: (2017-01-01) -
Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01) -
Modern treatment of patent ductus arteriosus – single center experience
by: Senka Mesihović Dinarević, et al.
Published: (2014-12-01) -
Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
by: Alain Fraisse, et al.
Published: (2020-09-01) -
Device closure of patent ductus arteriosus in interrupted inferior vena cava
by: Neeraj Aggarwal, et al.
Published: (2015-12-01)